chr12:7033626:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr12:7,033,626-7,051,484 |
hg38 | chr12:6,924,463-6,942,321 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Cardiomyopathy, Dilated | NA | BeFree | Detail | |
0.002 | myoclonic cerebellar dyssynergia | NA | GAD | Detail | |
<0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.001 | Primary biliary cirrhosis | Here, the authors discuss the current findings on two spontaneous (nonobese diab... | BeFree | 25057952 | Detail |
<0.001 | cholera | NA | BeFree | Detail | |
<0.001 | cholesteatoma | NOD-Like Receptor Signaling in Cholesteatoma. | BeFree | 25922834 | Detail |
<0.001 | Chondritis | NA | BeFree | Detail | |
<0.001 | chordoma | NA | BeFree | Detail | |
<0.001 | colitis | NA | BeFree | Detail | |
<0.001 | ulcerative colitis | NA | BeFree | Detail | |
<0.001 | colorectal carcinoma | NA | BeFree | Detail | |
<0.001 | Colorectal Neoplasms | NA | BeFree | Detail | |
<0.001 | Crohn Disease | NA | BeFree | Detail | |
<0.001 | Dengue Fever | NA | BeFree | Detail | |
<0.001 | Mental Depression | NA | BeFree | Detail | |
<0.001 | depressive disorder | NA | BeFree | Detail | |
<0.001 | dermatitis herpetiformis | NA | BeFree | Detail | |
<0.001 | Dermatitis, Atopic | NA | BeFree | Detail | |
0.021 | Diabetes | Endogenous miR-29b, spontaneously released from beta-cells within exosomes, stim... | BeFree | 25203514 | Detail |
0.021 | Diabetes | While numerous antigen-specific therapies prevent diabetes in NOD mice, successf... | BeFree | 25302633 | Detail |
0.021 | Diabetes | In the resulting 3A9 TCR:iHEL NOD.H2(k)-Chr12 mice, we observed a significant de... | BeFree | 25623266 | Detail |
0.021 | Diabetes | Similar effects were seen in the NOD mouse model, and in these mice, 1 week of t... | BeFree | 26368307 | Detail |
0.021 | diabetes mellitus | Endogenous miR-29b, spontaneously released from beta-cells within exosomes, stim... | BeFree | 25203514 | Detail |
0.021 | diabetes mellitus | While numerous antigen-specific therapies prevent diabetes in NOD mice, successf... | BeFree | 25302633 | Detail |
0.021 | diabetes mellitus | In the resulting 3A9 TCR:iHEL NOD.H2(k)-Chr12 mice, we observed a significant de... | BeFree | 25623266 | Detail |
0.021 | diabetes mellitus | Similar effects were seen in the NOD mouse model, and in these mice, 1 week of t... | BeFree | 26368307 | Detail |
0.017 | Diabetes Mellitus, Insulin-Dependent | Herein, we have tested the therapeutic potential of a soluble HLA-DR4-GAD65 271-... | BeFree | 24335553 | Detail |
0.017 | Diabetes Mellitus, Insulin-Dependent | The cells engrafted in HLA-A2-transgenic NOD-scid IL2rγ(null) mice and could be ... | BeFree | 25302633 | Detail |
0.017 | Diabetes Mellitus, Insulin-Dependent | Type 1 diabetes onset has been convincingly linked to infection by numerous ente... | BeFree | 25430610 | Detail |
0.017 | Diabetes Mellitus, Insulin-Dependent | Identification of autoreactive CD8+ T cell responses targeting chromogranin A in... | BeFree | 25958206 | Detail |
<0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
<0.001 | diphtheria | NA | BeFree | Detail | |
<0.001 | Down syndrome | NA | BeFree | Detail | |
<0.001 | Shigella Infections | NOD-like receptor signaling pathway and shigellosis related pathway were the mos... | BeFree | 24867262 | Detail |
<0.001 | Eczema | NA | BeFree | Detail | |
<0.001 | encephalitis | NA | BeFree | Detail | |
0.001 | Gall Bladder Diseases | Here, the authors discuss the current findings on two spontaneous (nonobese diab... | BeFree | 25057952 | Detail |
<0.001 | gastritis | NA | BeFree | Detail | |
<0.001 | glioblastoma | Treatment of GBM xenografts in NOD/SCID mice with NK cells from a KIR2DS2(+) don... | BeFree | 25381437 | Detail |
<0.001 | Glioma | NA | BeFree | Detail | |
<0.001 | glomerulonephritis | NA | BeFree | Detail | |
<0.001 | gonorrhea | We examined the ability of NOD1 and NOD2 to recognize Neisseria gonorrhoeae, and... | BeFree | 23884094 | Detail |
0.002 | Graft-vs-Host Disease | NOD/LtSz-scidIL2rg(-/-) (NSG) mice were used for our xenogeneic mouse model of G... | BeFree | 25596424 | Detail |
0.002 | Graft-vs-Host Disease | The therapeutic efficacy of HuMoSCs was evaluated by using a graft-versus-host d... | BeFree | 25630940 | Detail |
0.002 | Graft-vs-Host Disease | Sublethally irradiated NOD/Shi-scidIL2rγ(null) mice transplanted with human umbi... | BeFree | 25786689 | Detail |
<0.001 | chronic granulomatous disease | NA | BeFree | Detail | |
0.001 | cardiac arrest | However, at least half of dominant ataxias (SCAs) are caused by (CAG)n repeat ex... | BeFree | 25192506 | Detail |
<0.001 | hepatitis C | NA | BeFree | Detail | |
<0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
0.003 | HIV Infections | Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by a... | BeFree | 24593860 | Detail |
<0.001 | Hodgkin Disease | NA | BeFree | Detail | |
0.005 | Huntington disease | NA | BeFree,GAD | Detail | |
<0.001 | Hydatidiform mole | Mutations in NLRP7 (NOD-like-receptor family, pyrin domain containing 7) are res... | BeFree | 25082979 | Detail |
0.002 | hyperglycemia | Here we show that Deaf1-Var1 expression correlates with the severity of disease ... | BeFree | 25187368 | Detail |
0.012 | Immunologic Deficiency Syndromes | Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by a... | BeFree | 24593860 | Detail |
0.012 | Immunologic Deficiency Syndromes | Notably, CD24+ cells produce tumors following inoculation of as few as 500 cells... | BeFree | 24955581 | Detail |
0.012 | Immunologic Deficiency Syndromes | These findings were also observed in immunodeficient NOD/SCID mice treated with ... | BeFree | 25133686 | Detail |
0.012 | Immunologic Deficiency Syndromes | We generated a severe immunodeficient NOD/Shi-scid-IL-2Rγ(null) (NOG) mouse subs... | BeFree | 25712215 | Detail |
0.012 | Immunologic Deficiency Syndromes | Human CD34(+) human cord blood cells were transduced with an FV vector encoding ... | BeFree | 25786870 | Detail |
<0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
<0.001 | influenza | Expression of members of the NOD domain-like receptor family of inflammasome gen... | BeFree | 24652041 | Detail |
<0.001 | Intestinal Diseases | NA | BeFree | Detail | |
<0.001 | Krukenberg Tumor | NA | BeFree | Detail | |
<0.001 | Fibroid Tumor | NA | BeFree | Detail | |
0.005 | leukemia | Importantly, DLL4 blockade impaired growth of T-ALL cells in NOD/SCID mice and i... | BeFree | 25355291 | Detail |
0.005 | leukemia | We previously described that rapid engraftment of patient ALL cells transplanted... | BeFree | 25682198 | Detail |
0.005 | leukemia | Notably, C1 administration impaired the regeneration of leukemia in secondary se... | BeFree | 26224647 | Detail |
0.001 | chronic lymphocytic leukemia | Inhibition of IL-6 signaling with antibodies or small-molecule Janus kinase inhi... | BeFree | 26041742 | Detail |
<0.001 | lymphoid leukemia | Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukem... | BeFree | 24700491 | Detail |
0.002 | Acute lymphocytic leukemia | Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukem... | BeFree | 24700491 | Detail |
<0.001 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree | Detail | |
0.005 | Leukemia, Myelocytic, Acute | Although the in vivo NOD-SCID or NSG xenotransplantation model is currently stil... | BeFree | 25062630 | Detail |
<0.001 | myeloid leukemia | NA | BeFree | Detail | |
0.001 | Myeloid Leukemia, Chronic | The administration of actinomycin D, an inhibitor of de novo mRNA synthesis, pre... | BeFree | 25133686 | Detail |
<0.001 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
<0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
0.001 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
<0.001 | leukodystrophy | NA | BeFree | Detail | |
<0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
0.001 | lymphoma | NA | BeFree | Detail | |
<0.001 | lymphopenia | GIMAP5 has a key role in BB-DR rat and NOD mouse lymphopenia. | BeFree | 25964488 | Detail |
<0.001 | Lymphoproliferative Disorders | NA | BeFree | Detail | |
0.003 | Machado-Joseph disease | NA | BeFree,LHGDN | Detail | |
<0.001 | malaria | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of stomach | The NOD-like receptor signalling pathway in Helicobacter pylori infection and re... | BeFree | 24901306 | Detail |
<0.001 | melanoma | NA | BeFree | Detail | |
<0.001 | meningococcal meningitis | NA | BeFree | Detail | |
<0.001 | Meningitis, Pneumococcal | NA | BeFree | Detail | |
<0.001 | Metabolic Diseases | NA | BeFree | Detail | |
0.003 | multiple myeloma | NA | BeFree | Detail | |
<0.001 | Mycoses | NA | BeFree | Detail | |
<0.001 | myelofibrosis | We demonstrated that both splenic and peripheral blood (PB) MF CD34(+) cells equ... | BeFree | 25461253 | Detail |
<0.001 | myocarditis | NA | BeFree | Detail | |
<0.001 | myositis | NA | BeFree | Detail | |
0.002 | Myotonic dystrophy | NA | GAD | Detail | |
0.004 | Neoplasm Metastasis | In vitro and in vivo assays were carried out to evaluate the effects of NRP1 on ... | BeFree | 25231404 | Detail |
0.004 | Neoplasm Metastasis | In vivo studies with xenotransplant models in NOD-scid mice showed that OPN expr... | BeFree | 25531323 | Detail |
0.004 | Neoplasm Metastasis | NOD/SCID gamma mouse xenografts demonstrated tumor formation and metastasis. | BeFree | 25644184 | Detail |
<0.001 | nephroblastoma | NA | BeFree | Detail | |
<0.001 | neurilemmoma | NA | BeFree | Detail | |
<0.001 | neuroblastoma | NA | BeFree | Detail | |
<0.001 | Neurofibromatosis 2 | NA | BeFree | Detail | |
0.002 | obesity | Transcriptome analysis of human adipocytes implicates the NOD-like receptor path... | BeFree | 25011057 | Detail |
0.002 | obesity | Nucleotide-binding oligomerization domain (NOD) protein, as cytoplasmic receptor... | BeFree | 26052894 | Detail |
<0.001 | oligodendroglioma | NA | BeFree | Detail | |
<0.001 | otitis media | Expression of members of the NOD domain-like receptor family of inflammasome gen... | BeFree | 24652041 | Detail |
<0.001 | ovarian carcinoma | NOD/SCID nude mice experiments showed that ovarian cancer stem cell tumorigenici... | BeFree | 25491627 | Detail |
<0.001 | Pancreatic Neoplasm | In vivo treatment of orthotopic pancreatic tumors in NOD/SCID mice with GSI bloc... | BeFree | 24647545 | Detail |
<0.001 | papilloma | A biopsy of fresh tracheal papilloma was xenografted into a NOD-scid-IL2Rgamma(n... | BeFree | 25124839 | Detail |
<0.001 | Pelvic Pain | NA | BeFree | Detail | |
<0.001 | Polychondritis, Relapsing | NA | BeFree | Detail | |
<0.001 | polycystic ovary syndrome | Among these genes, we identified that several significant pathways, including th... | BeFree | 25051372 | Detail |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
<0.001 | Preleukemia | NA | BeFree | Detail | |
<0.001 | Prostatic Neoplasms | NA | BeFree | Detail | |
<0.001 | pulmonary edema | NA | BeFree | Detail | |
<0.001 | Rheumatism | NA | BeFree | Detail | |
<0.001 | Salivary Gland Diseases | NA | BeFree | Detail | |
0.005 | schizophrenia | NA | BeFree,GAD | Detail | |
<0.001 | sialadenitis | NA | BeFree | Detail | |
<0.001 | Spastic paraplegia | NA | BeFree | Detail | |
<0.001 | synovial sarcoma | NA | BeFree | Detail | |
0.001 | teratoma | NA | BeFree | Detail | |
0.002 | thyroiditis | NA | BeFree | Detail | |
<0.001 | Uterine Fibroids | NA | BeFree | Detail | |
<0.001 | vasculitis | NOD-like receptor signaling pathway and shigellosis related pathway were the mos... | BeFree | 24867262 | Detail |
<0.001 | Xerostomia | NA | BeFree | Detail | |
<0.001 | B-Cell Lymphomas | NA | BeFree | Detail | |
0.051 | severe combined immunodeficiency | Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by a... | BeFree | 24593860 | Detail |
0.051 | severe combined immunodeficiency | Additionally, in vivo studies showed that wogonin decreased the number of CML ce... | BeFree | 25149543 | Detail |
0.051 | severe combined immunodeficiency | TG20 cells possess all of the characteristic features of GSCs: the expression of... | BeFree | 25175359 | Detail |
0.051 | severe combined immunodeficiency | In vivo, DLL4 is expressed in the spleen and the bone marrow (BM) of NOD/SCID mi... | BeFree | 25355291 | Detail |
0.051 | severe combined immunodeficiency | NOD/SCID nude mice experiments showed that ovarian cancer stem cell tumorigenici... | BeFree | 25491627 | Detail |
0.051 | severe combined immunodeficiency | The human U87MG GBM cell line or patient-derived early passage GBM cells were ad... | BeFree | 25501993 | Detail |
0.051 | severe combined immunodeficiency | The therapeutic efficacy of HuMoSCs was evaluated by using a graft-versus-host d... | BeFree | 25630940 | Detail |
0.051 | severe combined immunodeficiency | NOD/SCID gamma mice produced useful patient-derived xenografts for orthotopic or... | BeFree | 25644184 | Detail |
0.051 | severe combined immunodeficiency | Orthotopic xenografts of human CM were established by subconjunctival injection ... | BeFree | 25722211 | Detail |
0.051 | severe combined immunodeficiency | Modified cells maintained their ability to engraft NOD/SCID/IL2rγ(null) mice and... | BeFree | 25733580 | Detail |
0.051 | severe combined immunodeficiency | Human CD34(+) human cord blood cells were transduced with an FV vector encoding ... | BeFree | 25786870 | Detail |
0.051 | severe combined immunodeficiency | NOD/SCID gamma mice bearing CEM or Molt4 xenografts were treated with 6-TG and P... | BeFree | 25917288 | Detail |
<0.001 | Mucopolysaccharidosis VII | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
0.016 | Ataxia, Spinocerebellar | NA | BeFree,GAD,LHGDN | Detail | |
<0.001 | Epstein-Barr Virus Infections | NA | BeFree | Detail | |
<0.001 | Complete atrioventricular block | NA | BeFree | Detail | |
0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
<0.001 | dacryoadenitis | NA | BeFree | Detail | |
<0.001 | adrenoleukodystrophy | NA | BeFree | Detail | |
<0.001 | Polyarthritis | NA | BeFree | Detail | |
<0.001 | Leukemic Infiltration | NA | BeFree | Detail | |
0.006 | Diabetes, Autoimmune | NA | BeFree | Detail | |
<0.001 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | uveal melanoma | NA | BeFree | Detail | |
<0.001 | Memory impairment | NA | BeFree | Detail | |
<0.001 | Cerebral atrophy | NA | BeFree | Detail | |
<0.001 | pancreatic carcinoma | The study suggested CEBPD, FOSB, SFN, KLF5, PTX3, NR4A3, IL-6, and NOD-like rece... | BeFree | 25409614 | Detail |
<0.001 | Gastrointestinal Stromal Tumors | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of lung | Here we evaluated the enhanced efficacy of cationic liposome-mediated delivery o... | BeFree | 24410728 | Detail |
<0.001 | Spastic syndrome | NA | BeFree | Detail | |
<0.001 | Impaired glucose tolerance | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | NA | BeFree | Detail | |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | cervix carcinoma | NA | BeFree | Detail | |
0.003 | Atrophic | NA | LHGDN | Detail | |
<0.001 | anaplastic oligodendroglioma | NA | BeFree | Detail | |
<0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | The study suggested CEBPD, FOSB, SFN, KLF5, PTX3, NR4A3, IL-6, and NOD-like rece... | BeFree | 25409614 | Detail |
<0.001 | juvenile myelomonocytic leukemia | NA | BeFree | Detail | |
0.001 | prediabetes syndrome | Some 75% of pre-diabetic NOD/DR4/B7 dTg mice treated with hu DEF-GAD65 chimera r... | BeFree | 24335553 | Detail |
<0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
0.003 | Pallidoluysian degeneration | NA | BeFree | Detail | |
<0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
<0.001 | Chronic pelvic pain of female | NA | BeFree | Detail | |
<0.001 | Chronic Infantile Neurological, Cutaneous, and Articular Syndrome | Activating-mutations in NOD-like receptor (NLR) family, pyrin domain-containing ... | BeFree | 25477279 | Detail |
<0.001 | endometrial carcinoma | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Chlamydia trachomatis infection | NA | BeFree | Detail | |
<0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
0.001 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
<0.001 | Hashimoto Disease | NA | BeFree | Detail | |
0.001 | breast carcinoma | NA | BeFree | Detail | |
<0.001 | Terminal illness | NA | BeFree | Detail | |
<0.001 | Carcinoma of lung | Here we evaluated the enhanced efficacy of cationic liposome-mediated delivery o... | BeFree | 24410728 | Detail |
<0.001 | colon carcinoma | Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by a... | BeFree | 24593860 | Detail |
<0.001 | stomach carcinoma | The NOD-like receptor signalling pathway in Helicobacter pylori infection and re... | BeFree | 24901306 | Detail |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Central neuroblastoma | NA | BeFree | Detail | |
<0.001 | Polychondritis | NA | BeFree | Detail | |
<0.001 | Well Differentiated Oligodendroglioma | NA | BeFree | Detail | |
0.120 | Myoclonic Epilepsies, Progressive | NA | CTD_human | Detail | |
<0.001 | Atrophy, Muscular, Spinobulbar | NA | BeFree | Detail | |
<0.001 | malignant pleural mesothelioma | The antitumor activity was displayed when orally administered to MPM-bearing NOD... | BeFree | 25952930 | Detail |
<0.001 | Helicobacter pylori infection | The NOD-like receptor signalling pathway in Helicobacter pylori infection and re... | BeFree | 24901306 | Detail |
<0.001 | Pelvic pain female | NA | BeFree | Detail | |
<0.001 | Endothelial dysfunction | Endoplasmic reticulum stress (ER stress)-associated thioredoxin-interacting prot... | BeFree | 25446924 | Detail |
<0.001 | Philadelphia chromosome positive | NA | BeFree | Detail | |
<0.001 | Retinoic acid syndrome | NA | BeFree | Detail | |
<0.001 | Stromal Neoplasm | NA | BeFree | Detail | |
<0.001 | ovarian neoplasm | NA | BeFree | Detail | |
0.002 | Genomic Instability | NA | GAD | Detail | |
<0.001 | autoimmune thyroiditis | NA | BeFree | Detail | |
<0.001 | Primary infection NOS | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of ovary | NOD/SCID nude mice experiments showed that ovarian cancer stem cell tumorigenici... | BeFree | 25491627 | Detail |
<0.001 | Congenital long QT syndrome | NA | BeFree | Detail | |
<0.001 | Brugada Syndrome (disorder) | NA | BeFree | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
<0.001 | Lymphocytic infiltration | NA | BeFree | Detail | |
<0.001 | Persistent infection | NA | BeFree | Detail | |
<0.001 | X-Linked Combined Immunodeficiency Diseases | NA | BeFree | Detail | |
<0.001 | Inflammatory disorder | Among these genes, we identified that several significant pathways, including th... | BeFree | 25051372 | Detail |
<0.001 | Chronic inflammatory disorder | The role of intracellular innate immune receptors, the NOD-like receptors, and t... | BeFree | 25922834 | Detail |
0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
<0.001 | Central nervous system leukaemia | NA | BeFree | Detail | |
<0.001 | pancreatic ductal adenocarcinoma | NOD-scid-IL2Rγ(null) mice were subcutaneously implanted with PDAC or PDAC(CBL-lo... | BeFree | 25348515 | Detail |
<0.001 | Cardiomyopathy, Familial Idiopathic | NA | BeFree | Detail | |
<0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
0.002 | Xenograft Model | NA | BeFree | Detail | |
<0.001 | colorectal cancer | NA | BeFree | Detail | |
<0.001 | Bulbo-Spinal Atrophy, X-Linked | NA | BeFree | Detail | |
<0.001 | uterine corpus cancer | NA | BeFree | Detail | |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | In vivo, DLL4 is expressed in the spleen and the bone marrow (BM) of NOD/SCID mi... | BeFree | 25355291 | Detail |
0.002 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukem... | BeFree | 24700491 | Detail |
0.001 | liver carcinoma | NA | BeFree | Detail | |
<0.001 | Cryopyrin-Associated Periodic Syndromes | NA | BeFree | Detail | |
<0.001 | Infectious Otitis Media | Expression of members of the NOD domain-like receptor family of inflammasome gen... | BeFree | 24652041 | Detail |
<0.001 | Hereditary Neurodegenerative Disorder | NA | BeFree | Detail | |
0.001 | Biliary System Disorder | Here, the authors discuss the current findings on two spontaneous (nonobese diab... | BeFree | 25057952 | Detail |
<0.001 | myelodysplastic syndrome | NA | BeFree | Detail | |
<0.001 | Hydatidiform mole, recurrent, 1 | Mutations in NLRP7 (NOD-like-receptor family, pyrin domain containing 7) are res... | BeFree | 25082979 | Detail |
<0.001 | Allergic disposition | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of ovary | NA | BeFree | Detail | |
<0.001 | Primary myelofibrosis | We demonstrated that both splenic and peripheral blood (PB) MF CD34(+) cells equ... | BeFree | 25461253 | Detail |
<0.001 | Anemia, Hemolytic | NA | BeFree | Detail | |
<0.001 | Anemia, Sickle Cell | NA | BeFree | Detail | |
<0.001 | antisocial personality disorder | NA | BeFree | Detail | |
<0.001 | arteriosclerosis | Endothelial dysfunction: the role of sterol regulatory element-binding protein-i... | BeFree | 25188917 | Detail |
<0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
0.001 | Ataxia | However, at least half of dominant ataxias (SCAs) are caused by (CAG)n repeat ex... | BeFree | 25192506 | Detail |
<0.001 | atherosclerosis | Endothelial dysfunction: the role of sterol regulatory element-binding protein-i... | BeFree | 25188917 | Detail |
0.002 | Autoimmune Diseases | The cells engrafted in HLA-A2-transgenic NOD-scid IL2rγ(null) mice and could be ... | BeFree | 25302633 | Detail |
<0.001 | Bacterial Infections | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
<0.001 | Blast Phase | NA | BeFree | Detail | |
<0.001 | Bone Diseases | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
<0.001 | Malignant tumor of colon | Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by a... | BeFree | 24593860 | Detail |
<0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
<0.001 | Non-small cell lung carcinoma | Surgically resected early-stage non-small-cell lung carcinoma (NSCLC) tumors wer... | BeFree | 26124487 | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, the authors discuss the current findings on two spontaneous (nonobese diabetic autoimmune bili... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NOD-Like Receptor Signaling in Cholesteatoma. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Endogenous miR-29b, spontaneously released from beta-cells within exosomes, stimulates TNFa secretio... | DisGeNET | Detail |
While numerous antigen-specific therapies prevent diabetes in NOD mice, successful translation of ro... | DisGeNET | Detail |
In the resulting 3A9 TCR:iHEL NOD.H2(k)-Chr12 mice, we observed a significant decrease in diabetes i... | DisGeNET | Detail |
Similar effects were seen in the NOD mouse model, and in these mice, 1 week of treatment was suffici... | DisGeNET | Detail |
Endogenous miR-29b, spontaneously released from beta-cells within exosomes, stimulates TNFa secretio... | DisGeNET | Detail |
While numerous antigen-specific therapies prevent diabetes in NOD mice, successful translation of ro... | DisGeNET | Detail |
In the resulting 3A9 TCR:iHEL NOD.H2(k)-Chr12 mice, we observed a significant decrease in diabetes i... | DisGeNET | Detail |
Similar effects were seen in the NOD mouse model, and in these mice, 1 week of treatment was suffici... | DisGeNET | Detail |
Herein, we have tested the therapeutic potential of a soluble HLA-DR4-GAD65 271-280 (hu DEF-GAD65) c... | DisGeNET | Detail |
The cells engrafted in HLA-A2-transgenic NOD-scid IL2rγ(null) mice and could be detected in the bloo... | DisGeNET | Detail |
Type 1 diabetes onset has been convincingly linked to infection by numerous enteroviruses including ... | DisGeNET | Detail |
Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NOD-like receptor signaling pathway and shigellosis related pathway were the most significant latent... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, the authors discuss the current findings on two spontaneous (nonobese diabetic autoimmune bili... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Treatment of GBM xenografts in NOD/SCID mice with NK cells from a KIR2DS2(+) donor lacking inhibitor... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We examined the ability of NOD1 and NOD2 to recognize Neisseria gonorrhoeae, and determined the role... | DisGeNET | Detail |
NOD/LtSz-scidIL2rg(-/-) (NSG) mice were used for our xenogeneic mouse model of GVHD. | DisGeNET | Detail |
The therapeutic efficacy of HuMoSCs was evaluated by using a graft-versus-host disease (GvHD) model ... | DisGeNET | Detail |
Sublethally irradiated NOD/Shi-scidIL2rγ(null) mice transplanted with human umbilical cord blood (Hu... | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, at least half of dominant ataxias (SCAs) are caused by (CAG)n repeat expansions resulting i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by adoptive transfer of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutations in NLRP7 (NOD-like-receptor family, pyrin domain containing 7) are responsible for a type ... | DisGeNET | Detail |
Here we show that Deaf1-Var1 expression correlates with the severity of disease in NOD mice and is r... | DisGeNET | Detail |
Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by adoptive transfer of ... | DisGeNET | Detail |
Notably, CD24+ cells produce tumors following inoculation of as few as 500 cells in immunodeficient ... | DisGeNET | Detail |
These findings were also observed in immunodeficient NOD/SCID mice treated with K562 EVs; BCR/ABL mR... | DisGeNET | Detail |
We generated a severe immunodeficient NOD/Shi-scid-IL-2Rγ(null) (NOG) mouse substrain expressing the... | DisGeNET | Detail |
Human CD34(+) human cord blood cells were transduced with an FV vector encoding a methylguanine meth... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of members of the NOD domain-like receptor family of inflammasome genes was significantly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Importantly, DLL4 blockade impaired growth of T-ALL cells in NOD/SCID mice and increased leukemia ce... | DisGeNET | Detail |
We previously described that rapid engraftment of patient ALL cells transplanted onto NOD/SCID mice ... | DisGeNET | Detail |
Notably, C1 administration impaired the regeneration of leukemia in secondary serial transplantation... | DisGeNET | Detail |
Inhibition of IL-6 signaling with antibodies or small-molecule Janus kinase inhibitors reversed tole... | DisGeNET | Detail |
Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice. | DisGeNET | Detail |
Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice. | DisGeNET | Detail |
NA | DisGeNET | Detail |
Although the in vivo NOD-SCID or NSG xenotransplantation model is currently still the favored assay ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The administration of actinomycin D, an inhibitor of de novo mRNA synthesis, prevented the abnormali... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
GIMAP5 has a key role in BB-DR rat and NOD mouse lymphopenia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrated that both splenic and peripheral blood (PB) MF CD34(+) cells equally share a defecti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In vitro and in vivo assays were carried out to evaluate the effects of NRP1 on malignant phenotypes... | DisGeNET | Detail |
In vivo studies with xenotransplant models in NOD-scid mice showed that OPN expression increases can... | DisGeNET | Detail |
NOD/SCID gamma mouse xenografts demonstrated tumor formation and metastasis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induc... | DisGeNET | Detail |
Nucleotide-binding oligomerization domain (NOD) protein, as cytoplasmic receptor of the innate immun... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of members of the NOD domain-like receptor family of inflammasome genes was significantly... | DisGeNET | Detail |
NOD/SCID nude mice experiments showed that ovarian cancer stem cell tumorigenicity was significantly... | DisGeNET | Detail |
In vivo treatment of orthotopic pancreatic tumors in NOD/SCID mice with GSI blocked tumor growth and... | DisGeNET | Detail |
A biopsy of fresh tracheal papilloma was xenografted into a NOD-scid-IL2Rgamma(null) (NSG) mouse. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Among these genes, we identified that several significant pathways, including the type I diabetes me... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NOD-like receptor signaling pathway and shigellosis related pathway were the most significant latent... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by adoptive transfer of ... | DisGeNET | Detail |
Additionally, in vivo studies showed that wogonin decreased the number of CML cells and prolonged su... | DisGeNET | Detail |
TG20 cells possess all of the characteristic features of GSCs: the expression of neural stem cell ma... | DisGeNET | Detail |
In vivo, DLL4 is expressed in the spleen and the bone marrow (BM) of NOD/SCID mice bearing T-ALL xen... | DisGeNET | Detail |
NOD/SCID nude mice experiments showed that ovarian cancer stem cell tumorigenicity was significantly... | DisGeNET | Detail |
The human U87MG GBM cell line or patient-derived early passage GBM cells were administered to the st... | DisGeNET | Detail |
The therapeutic efficacy of HuMoSCs was evaluated by using a graft-versus-host disease (GvHD) model ... | DisGeNET | Detail |
NOD/SCID gamma mice produced useful patient-derived xenografts for orthotopic or metastatic models. | DisGeNET | Detail |
Orthotopic xenografts of human CM were established by subconjunctival injection of three different C... | DisGeNET | Detail |
Modified cells maintained their ability to engraft NOD/SCID/IL2rγ(null) mice and to produce cells fr... | DisGeNET | Detail |
Human CD34(+) human cord blood cells were transduced with an FV vector encoding a methylguanine meth... | DisGeNET | Detail |
NOD/SCID gamma mice bearing CEM or Molt4 xenografts were treated with 6-TG and PDX alone or in combi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The study suggested CEBPD, FOSB, SFN, KLF5, PTX3, NR4A3, IL-6, and NOD-like receptor pathways were i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we evaluated the enhanced efficacy of cationic liposome-mediated delivery of FUS1 and human IL ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The study suggested CEBPD, FOSB, SFN, KLF5, PTX3, NR4A3, IL-6, and NOD-like receptor pathways were i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Some 75% of pre-diabetic NOD/DR4/B7 dTg mice treated with hu DEF-GAD65 chimera remained euglycemic a... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Activating-mutations in NOD-like receptor (NLR) family, pyrin domain-containing 3 (NLRP3) cause neon... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here we evaluated the enhanced efficacy of cationic liposome-mediated delivery of FUS1 and human IL ... | DisGeNET | Detail |
Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by adoptive transfer of ... | DisGeNET | Detail |
The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The antitumor activity was displayed when orally administered to MPM-bearing NOD/SCID mice. | DisGeNET | Detail |
The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Endoplasmic reticulum stress (ER stress)-associated thioredoxin-interacting protein (TXNIP) and NOD-... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NOD/SCID nude mice experiments showed that ovarian cancer stem cell tumorigenicity was significantly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Among these genes, we identified that several significant pathways, including the type I diabetes me... | DisGeNET | Detail |
The role of intracellular innate immune receptors, the NOD-like receptors, and their associated sign... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NOD-scid-IL2Rγ(null) mice were subcutaneously implanted with PDAC or PDAC(CBL-low) cells on opposite... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In vivo, DLL4 is expressed in the spleen and the bone marrow (BM) of NOD/SCID mice bearing T-ALL xen... | DisGeNET | Detail |
Attenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Expression of members of the NOD domain-like receptor family of inflammasome genes was significantly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, the authors discuss the current findings on two spontaneous (nonobese diabetic autoimmune bili... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutations in NLRP7 (NOD-like-receptor family, pyrin domain containing 7) are responsible for a type ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We demonstrated that both splenic and peripheral blood (PB) MF CD34(+) cells equally share a defecti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like rece... | DisGeNET | Detail |
NA | DisGeNET | Detail |
However, at least half of dominant ataxias (SCAs) are caused by (CAG)n repeat expansions resulting i... | DisGeNET | Detail |
Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like rece... | DisGeNET | Detail |
The cells engrafted in HLA-A2-transgenic NOD-scid IL2rγ(null) mice and could be detected in the bloo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Immunodeficient NOD SCID IL-2R(-/-) mice were immunologically reconstituted by adoptive transfer of ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Surgically resected early-stage non-small-cell lung carcinoma (NSCLC) tumors were implanted into non... | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- Genome
- hg19
- Position
- chr12:7,033,626-7,051,484
- Variant Type
- snv
Genome browser